The whole of my field has been flattened into a single lazy question: Did the health care system fail her?” writes Jennifer ...

Shihipar directs narrative projects and policy impact initiatives at the People, Place, and Health Collective at the Brown ...

More Trump drug pricing deals, GSK speeds up development of mRNA flu vaccine, and other biotech news ...

An NIH proposal to cap the number of research grants investigators can receive has drawn a mixed reception, the agency says.

Novartis and Bristol Myers Squibb have paused multiple cell therapy trials, while $480,000 has now become a routine price for ...

The federal spending bill has an important provision for researchers, and Trump announced more MFN deals with pharma firms.

The House voted to pass a stopgap funding bill that, for now, blocks a White House proposal to give political appointees more ...

Here are some of the key questions about the agreements the Trump administration has reached with drugmakers on pricing.

With clinical success on a personalized mRNA vaccine for melanoma, experts are hoping for a more stable future for the ...

John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. You’re reading the web edition of ...

Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

There has been a wealth of new treatment available” for migraine prevention, said a co-author of new guidelines released ...